Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Current Opinion in Immunology
|
July 16, 2008
Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement
Lucien Aarden, Sigrid R Ruuls, Gertjan Wolbink
Innate Immunity
|
April 25, 2015
An improved monocyte activation test using cryopreserved pooled human mononuclear cells
Shabnam Solati, Lucien Aarden, Sacha Zeerleder, et al.
Journal of Immunological Methods
|
December 1, 2010
Label-free assessment of high-affinity antibody-antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry
Theo Rispens, Henk Te Velthuis, Piet Hemker, et al.
Annals of the Rheumatic Diseases
|
May 14, 2013
A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies
Sandra Garcês, Marília Antunes, Elizabeth Benito-Garcia, et al.
Annals of the Rheumatic Diseases
|
January 10, 2013
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
Pauline A van Schouwenburg, Charlotte L Krieckaert, Theo Rispens, et al.
Journal of Immunological Methods
|
September 14, 2010
A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients
Pauline A van Schouwenburg, Geertje M Bartelds, Margreet H Hart, et al.
Annals of the Rheumatic Diseases
|
December 12, 2013
Key findings towards optimising adalimumab treatment: the concentration-effect curve
Mieke F Pouw, Charlotte L Krieckaert, Michael T Nurmohamed, et al.
Journal of Clinical Immunology
|
May 25, 2012
IgG4 production against adalimumab during long term treatment of RA patients
Pauline A van Schouwenburg, Charlotte L Krieckaert, Michael Nurmohamed, et al.
Frontiers in Immunology
|
August 22, 2017
Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
Els Beirnaert, Aline Desmyter, Silvia Spinelli, et al.
Arthritis and Rheumatism
|
March 2, 2006
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
Gerrit Jan Wolbink, Marijn Vis, Willem Lems, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Current Opinion in Immunology
|
July 16, 2008
Immunogenicity of anti-tumor necrosis factor antibodies-toward improved methods of anti-antibody measurement
Lucien Aarden, Sigrid R Ruuls, Gertjan Wolbink
Innate Immunity
|
April 25, 2015
An improved monocyte activation test using cryopreserved pooled human mononuclear cells
Shabnam Solati, Lucien Aarden, Sacha Zeerleder, et al.
Journal of Immunological Methods
|
December 1, 2010
Label-free assessment of high-affinity antibody-antigen binding constants. Comparison of bioassay, SPR, and PEIA-ellipsometry
Theo Rispens, Henk Te Velthuis, Piet Hemker, et al.
Annals of the Rheumatic Diseases
|
May 14, 2013
A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies
Sandra Garcês, Marília Antunes, Elizabeth Benito-Garcia, et al.
Annals of the Rheumatic Diseases
|
January 10, 2013
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
Pauline A van Schouwenburg, Charlotte L Krieckaert, Theo Rispens, et al.
Journal of Immunological Methods
|
September 14, 2010
A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients
Pauline A van Schouwenburg, Geertje M Bartelds, Margreet H Hart, et al.
Annals of the Rheumatic Diseases
|
December 12, 2013
Key findings towards optimising adalimumab treatment: the concentration-effect curve
Mieke F Pouw, Charlotte L Krieckaert, Michael T Nurmohamed, et al.
Journal of Clinical Immunology
|
May 25, 2012
IgG4 production against adalimumab during long term treatment of RA patients
Pauline A van Schouwenburg, Charlotte L Krieckaert, Michael Nurmohamed, et al.
Frontiers in Immunology
|
August 22, 2017
Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
Els Beirnaert, Aline Desmyter, Silvia Spinelli, et al.
Arthritis and Rheumatism
|
March 2, 2006
Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
Gerrit Jan Wolbink, Marijn Vis, Willem Lems, et al.
Page
of 2